AbbVie Affirms Q3 Adj EPS Guidance of $3.84-$3.88 vs $3.84 Est

Benzinga · 1d ago
AbbVie (NYSE:ABBV) affirms Q3 Adj EPS guidance from $3.84-$3.88 to $3.84-$3.88 vs $3.84 analyst estimate..